김광명 (이화여자대학교 약학대학)님 | 한빛사연구자 > 한빛사

이화여자대학교 약학대학

CV File

바이오센싱 및 나노바이오물질

최종업데이트 2023.06.12.

Low-dose radiation generated ROS-activatable doxorubicin prodrug loaded liposome nanoparticles for triple-negative breast cancer treatment
- J. Control. Release, Feb 27 2026, S0168-3659(26)00152-5 | https://doi.org/10.1016/j.jconrel.2026.114750
- 2026-02
- 바이오·의료융합
- 한빛사논문
High-dose treatment of cathepsin B-activatable doxorubicin prodrug nanoparticles that induce tumor-specific immunogenic cell death for immunotherapy of melanoma with minimal systemic toxicity
- Asian J. Pharm. Sci., Available online 13 January 2026 | https://doi.org/10.1016/j.ajps.2026.101123
- 2026-02
- 의약학
- 한빛사논문
Notch1 targeting siRNA delivery nanoparticles for rheumatoid arthritis therapy
- J. Control. Release, Oct 28 2015, 216 S0168-3659(15)30070-5 | https://doi.org/10.1016/j.jconrel.2015.08.025
- 2015-10
- 바이오·의료융합
- 상위피인용논문
Effective Degradation of Wild-Type and Mutant EGFR Using Self-Assembling Peptide-Derived PROTAC Nanoparticles (NanoTACs) for Cancer Therapy
- Adv. Mater., Dec 12 2025, | https://doi.org/10.1002/adma.202516974
- 2025-12
- 의약학
- 한빛사논문
Perspectives and trends in gas delivery systems based on ultrasound responsive nanomaterials for cancer therapy
- Adv. Drug Deliv. Rev., Dec 04 2025, S0169-409X(25)00232-7 | https://doi.org/10.1016/j.addr.2025.115747
- 2025-12
- 한빛사논문
Cathepsin B-Cleavable Doxorubicin Prodrug Nanoparticles for Eliciting Cancer-Specific Immunogenic Cell Death and Minimizing Systemic Toxicity
- Adv. Healthc. Mater., Dec 03 2025, | https://doi.org/10.1002/adhm.202504414
- 2025-12
- 의약학
- 한빛사논문
Cancer-Specific and Pro-Apoptotic PEGylated Liposomes Containing SMAC-Mimetic Doxorubicin Prodrug for Safe High-Dose Delivery in Pancreatic Cancer
- Adv. Healthc. Mater., Jul 21 2025, | https://doi.org/10.1002/adhm.202502018
- 2025-07
- 바이오·의료융합
- 한빛사논문
Activatable PROTAC nanoassembly for photodynamic PTP1B proteolysis enhances glioblastoma immunotherapy
- Acta Pharm. Sin. B, Available online 2 July 2025 | https://doi.org/10.1016/j.apsb.2025.06.028
- 2025-07
- 바이오·의료융합
- 한빛사논문
Dual Delivery of Light/Prodrug Nanoparticles Using Tumor-Implantable Micro Light-Emitting Diode on an Optofluidic System for Combinational Glioma Treatment
- ACS Nano, Apr 28 2025, | https://doi.org/10.1021/acsnano.4c17421
- 2025-04
- 바이오·의료융합
- 한빛사논문
Self-assembled Peptide-derived Proteolysis-targeting Chimera (PROTAC) Nanoparticles for Tumor-targeted and Durable PD-L1 Degradation in Cancer Immunotherapy
- Angew. Chem.-Int. Edit., Nov 21 2024, | https://doi.org/10.1002/anie.202414146
- 2024-11
- 바이오·의료융합
- 한빛사논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기